Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8623843 | Seminars in Arthritis and Rheumatism | 2017 | 36 Pages |
Abstract
When the first or even the second TNF inhibitor fails, switching to an alternate one is not an unreasonable clinical therapeutic decision.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Atul MD, David MD,